Cunyu Feng
Overview
Explore the profile of Cunyu Feng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
5
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lei L, Gao X, Zhai J, Liu S, Liu Q, Li C, et al.
Diabetes Obes Metab
. 2024 Mar;
26(6):2257-2266.
PMID: 38497233
Aim: Non-alcoholic fatty liver is the most common cause of chronic liver disease. GPR40 is a potential therapeutic target for energy metabolic disorders. GPR40 is a potential therapeutic target for...
2.
Li C, Liu Q, Ji W, Fu Y, Cao H, Huan Y, et al.
Front Med (Lausanne)
. 2023 Jun;
10:1164242.
PMID: 37359004
Background: L. (Sangzhi) alkaloid (SZ-A) is a new antidiabetic drug approved by the China National Medical Products Administration in 2020. Diabetic nephropathy (DN) is a common diabetic complication and an...
3.
Fu Y, Ji W, Liu Q, Zhang L, Li C, Huan Y, et al.
Int J Mol Sci
. 2022 Dec;
23(24).
PMID: 36555580
Voglibose is an α-glycosidase inhibitor that improves postprandial hyperglycemia and increases glucagon-like peptide-1 (GLP-1) secretion in patients with type 2 diabetes. Recently, there has been increasing interest in the anti-inflammatory...